Quantbot Technologies’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.31K Buy
+1,130
New +$5.74K ﹤0.01% 1576
2022
Q4
Sell
-11,604
Closed -$16K 1745
2022
Q3
$16K Buy
11,604
+2,000
+21% +$3.08K ﹤0.01% 1378
2022
Q2
$17K Sell
9,604
-15,700
-62% -$30.1K ﹤0.01% 1465
2022
Q1
$67K Buy
25,304
+150
+0.6% +$576 0.01% 1132
2021
Q4
$108K Buy
+25,154
New +$147K 0.01% 854
2021
Q1
Sell
-6,800
Closed -$44K 1469
2020
Q4
$44K Buy
+6,800
New +$48.6K ﹤0.01% 878
2020
Q3
Sell
-2,600
Closed -$21K 1344
2020
Q2
$21K Buy
+2,600
New +$24.1K ﹤0.01% 837
2019
Q4
Sell
-5,400
Closed -$39K 1273
2019
Q3
$39K Buy
+5,400
New +$53.3K ﹤0.01% 1030
2018
Q4
Sell
-4,046
Closed -$74K 1084
2018
Q3
$74K Buy
4,046
+1,607
+66% +$36.6K 0.01% 952
2018
Q2
$55K Buy
+2,439
New +$62.3K ﹤0.01% 970
2018
Q1
Sell
-3,115
Closed -$65K 1257
2017
Q4
$65K Buy
+3,115
New +$64.6K 0.01% 935

Other funds holding CTMX